搜索临床试验以:bendamustine and rituximab
总计272274个结果
-
Hoffmann-La Roche完全的
-
German CLL Study Group完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人复发性套细胞淋巴瘤 | 套细胞淋巴瘤 | CCND1 阳性 | CCND2阳性 | CCND3阳性 | CD20阳性 | 难治性套细胞淋巴瘤美国
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.完全的
-
InBios International, Inc.Biomedical Advanced Research and Development Authority; Fast-Track Drugs & Biologics, LLC完全的
-
Uppsala UniversityDalarna County Council, Sweden; Uppsala County Council, Sweden尚未招聘多发性骨髓瘤
-
Miltenyi Biomedicine GmbH招聘中中枢神经系统淋巴瘤 | 转化淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 (DLBCL) | 原发性纵隔 B 细胞淋巴瘤 (PMBCL) | 高级 B 细胞淋巴瘤 (HGBCL) | 复发性弥漫性大 B 细胞淋巴瘤美国
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, Inc完全的
-
Danderyd HospitalKarolinska Institutet; University of British Columbia完全的
-
Emory UniversityNational Cancer Institute (NCI); Genentech, Inc.; National Institutes of Health (NIH)主动,不招人
-
Aardvark Therapeutics, Inc.University of California, San Diego完全的
-
Ullevaal University HospitalAsker & Baerum Hospital未知
-
Aviceda Therapeutics, Inc.招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的滤泡性淋巴瘤 | 套细胞淋巴瘤 | 边缘区淋巴瘤 | 慢性淋巴细胞白血病 | 复发性弥漫性大 B 细胞淋巴瘤 | CD20阳性 | T 细胞非霍奇金淋巴瘤美国
-
National Cancer Center, KoreaSamsung Medical Center; Seoul National University Hospital; Seoul National University Bundang... 和其他合作者未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人3a 级滤泡性淋巴瘤 | Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor III 期 3 级滤泡性淋巴瘤 | Ann Arbor IV 期 3 级滤泡性淋巴瘤美国
-
Peking University People's Hospital完全的
-
Beijing Kejing Biotechnology Co., Ltd.Beijing Kejing Biotechnology Corp.撤销
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)完全的
-
University of California, San FranciscoUniversity of Rwanda; Ministry of Health, Rwanda; Rwanda Biomedical Centre完全的
-
University of Wisconsin, MadisonGenentech, Inc.撤销
-
Genentech, Inc.完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Biogen完全的
-
Rambam Health Care CampusTechnion, Israel Institute of Technology未知
-
Charite University, Berlin, GermanyHoffmann-La Roche未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor III 期惰性成人非霍奇金淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期惰性成人非霍奇金淋巴瘤 | Ann Arbor III 期边缘区淋巴瘤 | Ann Arbor IV 期边缘区淋巴瘤 | Ann Arbor III 期小淋巴细胞淋巴瘤 | Ann Arbor IV 期小淋巴细胞淋巴瘤美国
-
University of WashingtonMerck Sharp & Dohme LLC主动,不招人复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤美国
-
Gilead Sciences完全的套细胞淋巴瘤 | 慢性淋巴细胞白血病 | 惰性非霍奇金淋巴瘤美国
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的